<?xml version="1.0" encoding="UTF-8"?>
<p>Another series of experiments were realized to examine the potential role of NO/cGMP-mediated signaling in the tracheorelaxant effect of the 
 <italic>S. raeseri</italic> extract. To this end, tracheorelaxant function of the 
 <italic>S. raeseri</italic> extract (2 mg/mL) on CCh-induced tracheal ring contraction was further potentiated after incubation with bradykinin (NOS stimulator, 100 nM) (
 <italic>p</italic> &lt; 0.05, 
 <italic>n</italic> = 5-6), whereas ODQ (inhibitor of soluble guanylyl cyclase, 10 nM) (
 <italic>p</italic> &lt; 0.05, 
 <italic>n</italic> = 5) or L-NAME (nonspecific NOS inhibitor, 100 
 <italic>μ</italic>M) significantly decreased the 
 <italic>S. raeseri</italic> extract-induced relaxation (
 <italic>p</italic> &lt; 0.01, 
 <italic>n</italic> = 5) in the isolated rabbit trachea preparations compared with 
 <italic>S. raeseri</italic> extract (and cCCh) treated alone (
 <xref ref-type="fig" rid="fig3">Figure 3</xref>).
</p>
